Drug intelligence / Profile preview

(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C19H29N3O4S2 and a molecular weight of approximately 427.58 g/mol[1][6]. It features a benzene ring fused to a thiazine ring system with sulfonamide and piperazine substituents. The drug is listed as an experimental agent in chemical databases but does not have an established clinical indication or detailed mechanism of action reported in public sources[8]. Its structure suggests it may have been investigated as a research tool or potential drug candidate; however, no information on its pharmacological targets or therapeutic use is available.

Other names
(3R)-3-cyclopentyl-6-methyl-7-(4-methylpiperazin-1-sulfonyl)-3,4-dihydro-2H-1λ⁶,2-benzothiazine 1,1-dione(3R)-3-cyclopentyl-6-methyl-7-(4-methylpiperazine–1-sulfonyl)-3,4-dihydro–2H–1λ⁶,2-benzothiazine–1,1-dioneNS3NS-3NS 3

Beyond the preview

Go deeper on (3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call